*|MC:SUBJECT|*
BioRN News June 2023
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


Access to international innovation networks and industry-industry and industry-academia cooperation is essential to scale up healthcare solutions for patients.
Johnson & Johnson Innovation (JJI) has organized an innovation roadshow in Germany, which stopped in Heidelberg. The JJI Team met in-person with entrepreneurs, academics, tech transfer offices, and other leaders in life sciences innovation. The unique JJI external collaboration model ranging from incubation and custom R&D collaborations to company co-creation and investment together with several success stories was presented. This provided the audience with a deep understanding of their approach: put resources together to accelerate the process and combine expertise as early as possible.
[more]
The EIT Health Catapult finals took place last week at the Bits&Pretzels HealthTech Conference. Merck, dedicated member of the BioRN Cluster, is one of the industry partners of the Catapult Prize Alliance – fast tracking Europe´s best Health startups and awarding their Catapult Emerging Biotech winner with the “MERCK Prize for the most promising Biotech”. [more]

Nurturing and extending connections among regional innovation stakeholders is at the core of BioRN's activities. We bridge members regionally and towards other innovative ecosystems worldwide.
One of the tools that we use to achieve this, is the BioRN Annual Conference. Since 2009, each year the conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences. This year the conference will bring together experts in the field of cell and gene therapies and will address promises and challenges of next-generation approaches in the field. [more]
KEYNOTE Anke Schulte, Head of Cell & Gene Therapy Research and Preclinical Development, Bayer
Katja Betts, PROGEN
Carsten Müller-Tidow, University Hospital Heidelberg
Yunsi Olyslager, The Janssen Pharmaceutical Companies of Johnson & Johnson
Michael Platten, German Cancer Research Center


Connect to the delegation from Leuven and Belgium during the conference and in the pre-evening event. Take the chance to listen to interesting talks, have B2B meetings and network. [more]

"Appel" is the title of the EY Biotech Report this year. This emphasizes the prayerful calls for policymakers to simplify the framework conditions so that the potential can be fully exploited, financing gaps can be closed, and the opportunity for growth can be seized. [more]

Enjoy the news from our network and mark your calendar for the upcoming events!

Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New Members
03 | Events Spotlight
04 | Event Calendar & Discounts
05 | Open Positions
01| Research Highlights & News

10x Genomics: Single cell insights into an Alzheimer’s disease drug target [more]

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model [more]

DKFZ:
  • What determines whether breast cancer cells can form metastases? [more]
  • B cells promote liver cancer with dangerous dual strategy [more]
Heidelberg University: Helmholtz Institute for Translational Angiocardioscience founded [more]

NMI Natural and Medical Sciences Institute: How does schizophrenia develop? [more]

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1%, for the Treatment of the Signs and Symptoms of Dry Eye Disease [more]

Owkin receives European Medicines Agency letter of support for innovative AI-driven approach to oncology trial analysis [more]

Singleron and Sciomics – Collaborating in the pursuit of Precision Medicine [more]

Universitätsmedizin Mannheim (UMM): Early detection of sepsis through machine learning [more]
 

02 | New Members

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, vaccine and antibody protein drug, aiming to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 50 IND approvals since October 2017.
Our mission is to be a flexible provider of support, service, and consulting for clinical development of therapeutics especially for small biotech, startups-projects and investigator sponsored trials.
We offer solutions and hands-on-support for many problems young companies and project face when entering preclinical and clinical development. We give you access to our network of specialist and help you to select the right service partners, investigators and CROs as well as manage and control them. We work according to ICH-GCP and support you in setting up your own minimal QM system that fits your organization.

03 | Events Spotlight

04 | Event Calendar & Discounts

Geschäftsanbahnung Singapur & Malaysia: Chancen für deutsche Herstellende im Bereich Pharmaindustrie und Biotechnologie
July 03-07, 2023 - Singapur und Kuala Lumpur >>
 
Moving Towards Animal Free Cell Culture Media: Human Platelet Lysate - An Innovative Solution to FBS
July 03, 2023 - Online >>
 
Bayer's Expert Mondays: Alternative Financing Possibilities: Creative Ways to Bridge the 'Valley of Death'
July 03, 2023 - Online >>
 
Cancer genes beyond chromosomes
July 04, 2023 - Heidelberg & Online >>
 
Zukunft mit Biotechnologie Unternehmer:innentag 2023
July 05, 2023 - Berlin >>
 
MedTech Startup Feierabendbier @CUBEX ONE
July 05, 2023 - Mannheim >>
 
Online-Veranstaltung „Fokus Transferförderung – Kick-off zum DATIpilot“
July 07, 2023 - Online >>
 
Future Insight prize award ceremony 2023
July 11, 2023 - Online >>
 
Johann Anton Merck Award
July 12, 2023 - Online >>
 
Bayer's Expert Mondays: Medical Need: A Definition Challenge to Shape Your Value Proposition
July 17, 2023 - Online >>
 
Heidelberg Conference on Cancer Neuroscience (HCCN)
July 18-19, 2023 - Heidelberg >>
 
gründerspot: Wie sage ich es dem Arzt und Patienten? Marketing und Kommunikation für Gesundheitsprodukte
July 20, 2023 - Online >>
 
Bayer's Expert Mondays: Gating Decisions and How to Take the Right Ones
July 31, 2023 - Online >>
 
Biotechgate Digital Partnering
August 28 - September 01, 2023 - Online
Premium Access for BioRN Members >>

 
Life Sciences Baltics
September 20-21, 2023 - Vilnius, Lithuania
15 % discount on ticket price >>

 
Advanced Therapies Summit 2023
October 19, 2023 - Leuven, Belgium
October 16-18 & 20  - Online Matchmakinh
20 % discount for the on-site conference for BioRN Members >>

 
Bio-Europe
November 06-08, 2023 - Munich, Germany
900 € discount until 28th July and 10 % discount on later registration for BioRN Members  >>

 
Future Medicine Science Match 2023
November 09, 2023 - Berlin, Germany
Free tickets upon request available for BioRN Members >>

 
7th Immunotherapies & Innovations for Infectious Diseases Congress 2023 - I4ID2023
November 22-23, 2023 - Lyon, France
10 % discount for BioRN Members  >>

 
NLSDays 2023 - Nordic Life Science Days
November 29-30, 2023 - Copenhagen, Denmark
Booth in the German Pavillon (incl. Ticket for 1,200 €)
15% discount for BioRN Members >>

 
BioFIT Event 2023
December 12-13, 2023 - Marseille, France
20 % discount on ticket price until July 20 >>

 

05 | Open Positions


HWI pharma services GmbH: Quality Manager / Qualitätsmanager / Chemielaborant / Bachelor of Science / Apotheker / CTA (m/w/d) [more]

mfd Diagnostics GmbH: Biologe/-in (Bachelor oder Master) oder Biologisch-Technische(r) Assistent/-in (BTA) (m/w/d) oder vergleichbare Ausbildung [more]

ProtaGene: Director Genomics Research & Development and Cell & Gene Therapy analytical applications (m/f/d) [more]

Schrödinger: Internal Sales Representative [more]

Sciomics GmbH: BTA / Biologielaborant / MTA (m/w/d) [more]
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*